|
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results |
|
|
|
Titel: |
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results |
Auteur: |
Gener-Ricos, Georgina Haddad, Fadi G. Sasaki, Koji Issa, Ghayas C. Skinner, Jeffrey Masarova, Lucia Borthakur, Gautam Alvarado, Yesid Garcia-Manero, Guillermo Jabbour, Elias Kantarjian, Hagop |
Verschenen in: |
Clinical lymphoma myeloma and leukemia |
Paginering: |
Jaargang 23 () nr. 10 pagina's 742-748 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|